SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Effectiveness of Testing for Human Immunodeficiency Virus And Hepatitis C Virus Among Blood Transfusion Recipients
12 references·1 citing·42 second hop
Cost-Effectiveness of Testing for Human Immunodeficiency Virus And Hepatitis C Virus Among Blood Transfusion Recipients (2003)Cost-Effectiveness of Testing for Human I…Costeffectiveness of diagnostic tests (2001)Costeffectiveness of diagnost…Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood (2000)Prospective investigation of …Surveillance of blood transfusion safety: Contribution of the hemovigilance strategy in France (1998)Surveillance of blood transfu…Réflexions concernant le dépistage des acides nucléiques des virus des hépatites B et C et du virus de l'immunodéficience humaine dans la qualification biologique des dons (1998)Réflexions concernant le dépi…Safety of the Blood Supply in the United States: Opportunities and Controversies (1997)Safety of the Blood Supply in…Primer on Medical Decision Analysis: Part 4-Analyzing the Model and Interpreting the Results (1997)Primer on Medical Decision An…Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and Utilities (1997)Primer on Medical Decision An…Primer on Medical Decision Analysis: Part 2—Building a Tree (1997)Primer on Medical Decision An…Dépistage et détection précoce en transfusion sanguine : quand sont-ils indiqués ? (1997)Dépistage et détection précoc…Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood (1997)Cost‐effectiveness of expande…Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for reporting…Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…Évaluation du dépistage sérologique pré- et post-transfusionnel en France en 2001 (2004)Évaluation du dépistage sérol…Users' Guides to the Medical Literature (1995)Primer on Medical Decision Analysis: Part 1—Getting Started (1997)Primer on Medical Decision Analysis: Part 5—Working with Markov Processes (1997)Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Psychology and Economics (1997)Advances in Cost-Effectiveness Analysis of Health Interventions (1999)Challenges in Systematic Reviews of Diagnostic Technologies (2005)Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening (1990)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)Hemovigilance in France (2000)Bilan et perspectives du fonctionnement de l’hémovigilance française et des données recueillies sur 9 ans (2003)Transfusion sanguine : en toute sécurité infectieuse (2014)Clinical Decision Analysis (1980)The Markov Process in Medical Prognosis (1983)Preference-Based Measures in Economic Evaluation in Health Care (2000)Equity and the economic evaluation of healthcare (2001)A review and critique of modelling in prioritising and designing screening programmes (2007)Measurement of health state utilities for economic appraisal (1986)Clinical decision analysis (2005)Multiparameter Evidence Synthesis in Epidemiology and Medical Decision-Making: Current Approaches (2005)Overview of research on health-related quality of life in patients with chronic liver disease. (2008)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Patient and Community Preferences for Outcomes in Prostate Cancer (2003)The Half-Cycle Correction Explained: Two Alternative Pedagogical Approaches (2008)Cost-Minimization Analysis of Robotic-Assisted, Laparoscopic, and Abdominal Sacrocolpopexy (2010)Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)The Risk of Transfusion-Transmitted Infection (1992)An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy (2002)Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy (2005)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)
this work references cited by second hop

References

  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,274 cited
  • 1996Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine1,037 cited
  • 1997Primer on Medical Decision Analysis: Part 2—Building a Tree238 cited
  • 1997Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and Utilities221 cited
  • 1997Primer on Medical Decision Analysis: Part 4-Analyzing the Model and Interpreting the Results176 cited
  • 1997Safety of the Blood Supply in the United States: Opportunities and Controversies173 cited
  • 1997Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood130 cited
  • 2000Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood101 cited
  • 2001Costeffectiveness of diagnostic tests55 cited
  • 1998Surveillance of blood transfusion safety: Contribution of the hemovigilance strategy in France32 cited
  • 1997Dépistage et détection précoce en transfusion sanguine : quand sont-ils indiqués ?11 cited
  • 1998Réflexions concernant le dépistage des acides nucléiques des virus des hépatites B et C et du virus de l'immunodéficience humaine dans la qualification biologique des dons6 cited

Cited by

  • 2004Évaluation du dépistage sérologique pré- et post-transfusionnel en France en 20015 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work